PMID: 3756770Nov 15, 1986Paper

The long-term effect of cisplatin on renal function

Cancer
P FjeldborgP E Helkjaer

Abstract

The long-term effect of cisplatin on renal function was studied in a follow-up investigation, 16 to 52 months after chemotherapy in 22 patients with disseminated nonseminomatous testicular cancer. The median cumulated cisplatin dose was 452 mg/m2 (range, 275-650 mg/m2). Prehydration with isotonic saline secured diuresis above 100 ml/hour. GFR (glomerular filtration rate: 51Cr-EDTA clearance) fell by 12.5% (median, P less than 0.01) compared with the pretreatment level. Effective renal plasma flow (125I-hippuran clearance) was estimated to be likewise reduced. The serum creatinine level rose 8 mumol/1 (median, P less than 0.05) during the treatment period with no further rise afterwards. Serum magnesium and urinary excretion of beta-2-microglobulin were normal. The results indicate a moderate and permanent reduction in GFR with no signs of long-term tubular defects in patients treated with cisplatin.

References

Jun 1, 1979·Annals of Internal Medicine·R L Schilsky, T Anderson
Apr 1, 1977·Cancer·J C Gonzales-VitaleS S Sternberg
Nov 1, 1972·Scandinavian Journal of Clinical and Laboratory Investigation·J Bröchner-Mortensen
Feb 1, 1972·Scandinavian Journal of Clinical and Laboratory Investigation·P E Evrin, L Wibell
May 1, 1984·Annals of Internal Medicine·P J Loehrer, L H Einhorn
Apr 1, 1980·Clinical Pharmacology and Therapeutics·B R JonesM M Reidenberg
Nov 1, 1981·Annals of Internal Medicine·J D Blachley, J B Hill

❮ Previous
Next ❯

Citations

Dec 10, 1999·Seminars in Surgical Oncology·C KollmannsbergerC Bokemeyer
Jan 1, 1992·Cancer Chemotherapy and Pharmacology·M E RobbinsE Whitehouse
Jan 1, 1994·Cancer Chemotherapy and Pharmacology·V PinzaniP Balmès
Jan 1, 1990·Cancer Chemotherapy and Pharmacology·G MilanoJ L Lagrange
Jan 1, 1989·Cancer Chemotherapy and Pharmacology·G Daugaard, U Abildgaard
Feb 15, 2001·Bulletin of Experimental Biology and Medicine·N V LyubimovaN E Kushlinskii
Apr 1, 1996·Critical Reviews in Oncology/hematology·S CulineJ P Droz
Sep 28, 2001·European Journal of Obstetrics, Gynecology, and Reproductive Biology·C PedainW Künzel
Apr 1, 1995·The Journal of Clinical Investigation·P A Wood, W J Hrushesky
Jul 31, 2003·Drugs·Uzair B Chaudhary, Jason R Haldas
Jan 23, 2016·Cancer Chemotherapy and Pharmacology·Yohei FunakoshiHironobu Minami
Jan 1, 1988·The American Journal of the Medical Sciences·S UmekiR Soejima
Oct 1, 1989·The American Journal of the Medical Sciences·S UmekiR Soejima
Jun 21, 2011·European Urology·Robert AbouassalyCora N Sternberg
May 17, 2011·Hematology/oncology Clinics of North America·Timothy Gilligan
Oct 5, 2007·The Lancet Oncology·Thankamma V AjithkumarHelen M Hatcher
Aug 10, 2007·Journal of Applied Toxicology : JAT·Takeki UeharaToshiyuki Maruyama
Jan 1, 1991·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·D P DearnaleyM J Peckham
Nov 1, 1992·Critical Reviews in Oncology/hematology·G Daugaard, U Abildgaard
Feb 1, 1989·European Journal of Cancer & Clinical Oncology·C R HamiltonA Horwich
Nov 23, 2005·Urologic Oncology·Robert AbouassalyDerek Raghavan
Aug 1, 1991·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·F A StewartF A de Wolff
Apr 14, 2016·Clinical Journal of the American Society of Nephrology : CJASN·Sheron LatchaCarlos D Flombaum
Mar 1, 1992·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·N Marcussen, N O Jacobsen
Mar 16, 2011·Nature Reviews. Urology·Chunkit Fung, David J Vaughn
Jan 1, 1987·Pediatric Hematology and Oncology·G VassalJ Lemerle
Feb 12, 2020·Acta Oncologica·Ragnhild V NomeSophie D Fosså
Apr 25, 2001·American Journal of Clinical Oncology·A CubilloM González Barón
Dec 22, 1999·International Journal of Cancer. Journal International Du Cancer·J T HartmannC Bokemeyer
Sep 1, 1990·The Journal of Urology·S R SmalleyR L Richardson
Sep 18, 2020·Toxicology Letters·Mikail SahinAmol Fatangare
Sep 22, 1998·Current Problems in Cancer·C R Nichols

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.